Electronic Documents Requiring Electronic Signatures: Understanding FDA Part 11 and Japan’s ER/ES Guidelines
Outlook for Part 11 Revision: Historical Context and Current Status
The Commencement of ER/ES Inspections by Regulatory Authorities: Historical Context and Current Practices
Understanding Part 11 in FDA Inspections: Key Considerations for Pharmaceutical and Medical Device Companies
Have Part 11 Inspections Disappeared? Understanding Current Regulatory Trends
FDA Form 483 Response Requirements and Best Practices
Understanding Regulatory Audits: Purpose, Misconceptions, and Modern Approaches
FDA Inspection Response and the “15-Minute Rule” (Revised Edition)